Showing 23,074 news articles about PEP

Filters Content type: Editors' picks Topic: PEP

Post-exposure prophylaxis involves taking a 28-day course of anti-HIV drugs, after possible exposure to HIV. It may be used by healthcare workers (occupational PEP) or after sex (post-exposure prophylaxis after sexual exposure, PEPSE, also known as non-occupational PEP or nPEP).

Access to healthcare

Twice-Yearly Lenacapavir Injection for HIV Prevention in Nigeria: The Real Test Is Access

Editor's pick
Nigeria Health Watch
6 February 2026
Global health initiatives

By Slashing Foreign Aid, Trump Is Fueling the Spread of HIV in Uganda

Editor's pick
The Intercept (free registration required)
11 February 2026
Global health initiatives

Trump quietly restores almost all HIV funding

Editor's pick
The Telegraph
11 February 2026
Finance & funding

EU to Pledge €700 Million to Global Fund, Undercutting Previous Commitments

Editor's pick
Health Policy Watch
11 February 2026
People who inject drugs

In British Columbia, Drug Policy Rollbacks Are Limiting HIV Care

Editor's pick
Filter
11 February 2026
Sleep

How to Recognize HIV’s Distinct Pattern of Disordered Sleep—and Know When to Refer

Editor's pick
TheBodyPro
11 February 2026
Treatment guidelines

Cancer Screening Gaps Leave People With HIV at Elevated Risk

Editor's pick
Medscape (requires free registration)
11 February 2026
Global health initiatives

As US cash dries up South Africa's fight to stop Aids gets harder

Editor's pick
BBC News
11 February 2026
Harm reduction

Drug injection fades as smoking grows more common, marking sea change in U.S. fentanyl epidemic

Editor's pick
STAT (requires free registration)
12 February 2026
Ageing & HIV

Frailty and Falls Have a High Cost for People With HIV

Editor's pick
POZ
12 February 2026
Access to healthcare

Civil Society Demands Access Strategy for Merck’s Promising Long-Acting HIV Prevention Pill Covering all Low- and Middle-Income Countries

Editor's pick
Health GAP (Global Access Project)
12 February 2026
Finance & funding

Proposed $600 million federal cut to public health funds could disrupt HIV prevention efforts in 4 US states

Editor's pick
CIDRAP
12 February 2026
HIV prevention policy

Life after DREAMS: Kenya’s girls navigate HIV risk without US support

Editor's pick
Devex (requires free registration)
18 February 2026
Harm reduction

Fewer overdose deaths among needle and syringe program participants

Editor's pick
Karolinska Institutet
18 February 2026
Conference announcements & declarations

CROI 2026: Introduction and main likely themes

Editor's pick
i-Base
23 February 2026
Injectable & long-acting PrEP

Zimbabwe Rolls Out New HIV Prevention Drug Lenacapavir

Editor's pick
Medscape (requires free registration)
23 February 2026
Conference announcements & declarations

At an Inflection Point in HIV Science: Nicolas Chomont, PhD, Looks Ahead to CROI 2026

Editor's pick
American Journal of Managed Care
23 February 2026
Coronavirus

HIV infection linked to increased risk of long COVID

Editor's pick
CIDRAP
23 February 2026
Hepatitis & HIV

The fight against hepatitis in Africa hangs in the balance after US cuts: Clinics closed, fewer tests and canceled research

Editor's pick
El País
23 February 2026
Neurological & cognitive problems

Parkinsonism in People With Virally Suppressed HIV: New Research Offers a Closer Look

Editor's pick
TheBodyPro
23 February 2026
Finance & funding

Global Fund Board Welcomes Final Eighth Replenishment Outcome of US$12.64 Billion, Backs Strategic Shifts to Advance Countries’ Path to Self-Reliance

Editor's pick
Global Fund
23 February 2026
Sexually transmitted infections prevention

DoxyPEP and antibiotic resistance: What have we learned so far?

Editor's pick
CATIE Blog
23 February 2026
Employment

The economic cost of HIV: new study quantifies impact on work and income

Editor's pick
University of Amsterdam
23 February 2026
Global health initiatives

Global Fund fundraising shortfall hits country allocations

Editor's pick
Devex (requires free registration)
23 February 2026